Search

Frequency analysis and topographic mapping of EEG were studied in 20 consecutive patients with mild stroke and in 20 age-matched normal subjects. Abnormally large increases in delta and decreases in alpha activity were seen over the scalp in 17 of 20 patients and in no normal subjects. Theta was unreliable by itself. The scalp area so localized appeared correct in each case compared with signs, symptoms, and neuroimaging studies. These computerized EEG analysis techniques were abnormal significantly more often than routine EEGs. The results obtained here with simple techniques agree with past studies done with more complex types of EEG analysis.

In elderly patients presenting to an ambulatory practice with complaints of cognitive disturbance, early dementia must be differentiated from depression. The present paper describes the application of standard electroencephalography and evoked potential testing (EEG/EP) and computerized electroencephalography with evoked potential mapping (CEEG/EPM) in the analysis of 64 elderly patients complaining of cognitive disturbance. Although previous reports have claimed a sensitivity level of up to 80% for EEG in demented patients, it appears that a lower sensitivity (37% for EEG alone and 61% for EEG/EP) may be expected at the time of early presentation according to the present study. No EEG/EP abnormalities were detected in patients with depression. In demented patients, CEEG/EPM was abnormal in 85% (46 of 54) of cases compared to 10% (1 of 10) of cases with depression. Specific information was obtained from EEG/EP studies that helped differentiate the various causes of dementia in three cases. In CEEG/EPM studies, a pattern of relative suppression of alpha activity or suppressed auditory P300 amplitude in the posterior parietal regions was observed in 11 or 23 (48%) patients with Alzheimer's disease and 2 of 31 (6%) patients with other forms of dementia. None of the depressed patients demonstrated such changes. Based on the present study, it appears that computerized techniques may hold promise as an adjunct to standard EEG evaluation of patients with mild cognitive change in whom diagnosis of dementia or depression is in doubt. Although standard EEG rarely demonstrates characteristic changes that may help differentiate causes of dementia, CEEG/EPM appears to demonstrate, on occasion, abnormalities in the posterior temporal and parietal regions in patients with a diagnosis of probable Alzheimer's disease and rarely in other forms of dementia or depression.

Topographic maps of EEG can contain artifacts that are foreign to clinical electroencephalographers trained to read traditional EEG records. Several spatial artifacts are described and discussed here, including the centrifugal effect, ring enhancement, spatial aliasing, electrode hills and holes, color-step effects, and restriction of minima/maxima to electrode sites. Users of quantitated EEG with topographic maps should be aware of these artifacts and should have a high suspicion for other analogous artifactual spatial phenomena when interpreting individual patient records.

To evaluate the assessment of thoracic outlet compression syndrome (TOS) by objective methods, we prospectively studied a group of 80 consecutive patients with disabling TOS who had been selected for surgical therapy. Comprehensive pre- and postoperative neurophysiologic tests were used and included electromyography, nerve conduction times, F wave determination, and somatosensory evoked potentials (SEPs) of median and ulnar nerves in neutral and stressed positions. Measurements were made of Erb's point peak (N9), cervical peak (P/N13), and cortical complex (N18-P22). Amplitude ratios were calculated for each side, and interpeak latencies were measured for N9-P/N13, P/N13-N18, and N9-N18. SEP results were abnormal on the affected side in 59 of 80 patients (74%); ulnar peak amplitudes were either less than 33% of median, reduced by more than 50% in the stressed position, or reduced by more than 50% when compared with the contralateral side. Of 64 patients studied pre- and postoperatively with SEP, 40 of 47 abnormal tests showed improvement, with 30 of these returning to normal values in the early postoperative period. Excellent clinical correlation was evident in 43 of these 47 patients (92%) who had pre- and postoperative tests; with relief of symptoms reflected in improved SEP, or continued symptoms explained by evidence of persistent or residual nerve dysfunction. The present methodology and criteria for test interpretation demonstrate that SEP can document the neurocompressive component of TOS and provide an objective assessment of pre- and postoperative clinical observations.

Background: Regenerative medicine is a medical subspecialty that seeks to recruit and enhance the body’s own inherent healing armamentarium in the treatment of patient pathology. This therapy’s intention is to assist in the repair, and to potentially replace or restore damaged tissue through the use of autologous or allogenic biologics. This field is rising like a Phoenix from the ashes of underperforming conventional therapy midst the hopes and high expectations of patients and medical personnel alike. But, because this is a relatively new area of medicine that has yet to substantiate its outcomes, care must be taken in its public presentation and promises as well as in its use. Objective: To provide guidance for the responsible, safe, and effective use of biologic therapy in the lumbar spine. To present a template on which to build standardized therapies using biologics. To ground potential administrators of biologics in the knowledge of the current outcome statistics and to stimulate those interested in providing biologic therapy to participate in high quality research that will ultimately promote and further advance this area of medicine. Methods: The methodology used has included the development of objectives and key questions. A panel of experts from various medical specialties and subspecialties as well as differing regions collaborated in the formation of these guidelines and submitted (if any) their appropriate disclosures of conflicts of interest. Trustworthy standards were employed in the creation of these guidelines. The literature pertaining to regenerative medicine, its effectiveness, and adverse consequences was thoroughly reviewed using a best evidence synthesis of the available literature. The grading for recommendation was provided as described by the Agency for Healthcare Research and Quality (AHRQ). Summary of Evidence: Lumbar Disc Injections: Based on the available evidence regarding the use of platelet-rich plasma (PRP), including one high-quality randomized controlled trial (RCT), multiple moderate-quality observational studies, a single-arm meta-analysis and evidence from a systematic review, the qualitative evidence has been assessed as Level III (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best-evidence synthesis. Based on the available evidence regarding the use of medicinal signaling/ mesenchymal stem cell (MSCs) with a high-quality RCT, multiple moderate-quality observational studies, a single-arm meta-analysis, and 2 systematic reviews, the qualitative evidence has been assessed as Level III (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best evidence synthesis. Lumbar Epidural Injections Based on one high-quality RCT, multiple relevant moderate-quality observational studies and a single-arm meta-analysis, the qualitative evidence has been assessed as Level IV (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best evidence synthesis. Lumbar Facet Joint Injections Based on one high-quality RCT and 2 moderate-quality observational studies, the qualitative evidence for facet joint injections with PRP has been assessed as Level IV (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best evidence synthesis. Sacroiliac Joint Injection Based on one high-quality RCT, one moderate-quality observational study, and one low-quality case report, the qualitative evidence has been assessed as Level IV (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best evidence synthesis. Conclusion: Based on the evidence synthesis summarized above, there is Level III evidence for intradiscal injections of PRP and MSCs, whereas the evidence is considered Level IV for lumbar facet joint, lumbar epidural, and sacroiliac joint injections of PRP, (on a scale of Level I through V) using a qualitative modified approach to the grading of evidence based on best evidence synthesis. Regenerative therapy should be provided to patients following diagnostic evidence of a need for biologic therapy, following a thorough discussion of the patient’s needs and expectations, after properly educating the patient on the use and administration of biologics and in full light of the patient’s medical history. Regenerative therapy may be provided independently or in conjunction with other modalities of treatment including a structured exercise program, physical therapy, behavioral therapy, and along with the appropriate conventional medical therapy as necessary. Appropriate precautions should be taken into consideration and followed prior to performing biologic therapy. Multiple guidelines from the Food and Drug Administration (FDA), potential limitations in the use of biologic therapy and the appropriate requirements for compliance with the FDA have been detailed in these guidelines. Key words: Regenerative medicine, platelet-rich plasma, medicinal signaling cells, mesenchymal stem cells, stromal vascular fraction, bone marrow concentrate, chronic low back pain, discogenic pain, facet joint pain, Food and Drug Administration, minimal manipulation, evidence synthesis